H. Bachelez

13.8k total citations · 2 hit papers
171 papers, 7.1k citations indexed

About

H. Bachelez is a scholar working on Immunology, Dermatology and Epidemiology. According to data from OpenAlex, H. Bachelez has authored 171 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Immunology, 86 papers in Dermatology and 44 papers in Epidemiology. Recurrent topics in H. Bachelez's work include Psoriasis: Treatment and Pathogenesis (76 papers), Cutaneous lymphoproliferative disorders research (36 papers) and Dermatology and Skin Diseases (34 papers). H. Bachelez is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (76 papers), Cutaneous lymphoproliferative disorders research (36 papers) and Dermatology and Skin Diseases (34 papers). H. Bachelez collaborates with scholars based in France, United States and United Kingdom. H. Bachelez's co-authors include Louis Dubertret, M. Viguier, C. Paul, F. Aubin, L. Puig, Laurence Michel, Juliet N. Barker, S. Aractingi, Patrice Morel and Giampiero Girolomoni and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

H. Bachelez

161 papers receiving 6.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Foxp3 Expressing CD4+CD25high Regulatory T Cells Are Overrepresented in Human Metastatic Melanoma Lymph Nodes and Inhibit the Function of Infiltrating T Cells

2004 561 citations M. Viguier, Fabrice Lemaı̂tre et al. The Journal of Immunology profile →
Patient perspectives in the management of psoriasis: Results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey

2014 411 citations Mark Lebwohl, H. Bachelez et al. Journal of the American Academy of Dermatology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
H. Bachelez	4.2k	3.0k	1.4k	1.4k	1.1k	171	7.1k
S. Aractingi	3.0k 0.7×	2.2k 0.7×	869 0.6×	1.2k 0.9×	1.2k 1.1×	258	7.2k
Bárður Sigurgeirsson	3.2k 0.8×	3.0k 1.0×	843 0.6×	3.2k 2.3×	1.6k 1.4×	85	7.6k
Helgi Valdimarsson	5.1k 1.2×	2.2k 0.7×	842 0.6×	1.1k 0.8×	1.6k 1.4×	173	8.2k
M. Bagot	2.5k 0.6×	4.0k 1.3×	2.7k 2.0×	2.2k 1.6×	1.6k 1.4×	365	8.2k
Martine Bagot	1.8k 0.4×	2.4k 0.8×	1.7k 1.3×	1.4k 1.1×	630 0.5×	183	4.9k
Menno A. de Rie	2.6k 0.6×	2.1k 0.7×	592 0.4×	988 0.7×	578 0.5×	133	4.8k
Neil J. Korman	5.6k 1.3×	4.0k 1.3×	3.1k 2.3×	940 0.7×	2.5k 2.2×	163	9.8k
Curdin Conrad	5.9k 1.4×	2.2k 0.7×	557 0.4×	587 0.4×	832 0.7×	108	7.5k
Hernán Valdez	2.5k 0.6×	2.0k 0.7×	364 0.3×	1.4k 1.0×	1.6k 1.4×	154	7.1k
Michael Sticherling	2.3k 0.5×	1.0k 0.3×	1.4k 1.0×	445 0.3×	1.8k 1.6×	214	5.9k

Countries citing papers authored by H. Bachelez

Since Specialization

Citations

This map shows the geographic impact of H. Bachelez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Bachelez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Bachelez more than expected).

Fields of papers citing papers by H. Bachelez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Bachelez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Bachelez. The network helps show where H. Bachelez may publish in the future.

Co-authorship network of co-authors of H. Bachelez

This figure shows the co-authorship network connecting the top 25 collaborators of H. Bachelez. A scholar is included among the top collaborators of H. Bachelez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Bachelez. H. Bachelez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Choon, Siew Eng, Peter van de Kerkhof, & H. Bachelez. (2025). Comments on Consensus for Generalized Pustular Psoriasis—Reply. JAMA Dermatology. 161(3). 341–341.

Boussetta, Nadia, Ting‐Di Wu, Morgane Le Gall, et al.. (2024). Skin hepcidin initiates psoriasiform skin inflammation via Fe-driven hyperproliferation and neutrophil recruitment. Nature Communications. 15(1). 6718–6718. 12 indexed citations

Elewski, Boni E., Mark Lebwohl, Milan J. Anadkat, et al.. (2023). Rapid and sustained improvements in Generalized Pustular Psoriasis Physician Global Assessment scores with spesolimab for treatment of generalized pustular psoriasis flares in the randomized, placebo-controlled Effisayil 1 study. Journal of the American Academy of Dermatology. 89(1). 36–44. 21 indexed citations

Mahé, E., M.‐A. Richard, Yann De Rycke, et al.. (2023). Impact of the first wave of the COVID-19 pandemic on the treatment of psoriasis with systemic therapies in France: Results from the PSOBIOTEQ cohort. Annales de Dermatologie et de Vénéréologie. 150(2). 101–108. 1 indexed citations

Mahé, E., M.‐A. Richard, Yann De Rycke, et al.. (2021). Impact de l’épidémie de COVID-19 lors de la 1ère vague sur les patients de la cohorte PSOBIOTEQ traités pour psoriasis cutané. PubMed Central. 1(8). A298–A299. 1 indexed citations

Assan, Florence, J. Gottlieb, Florence Tubach, et al.. (2020). Anti-Saccharomyces cerevisiae IgG and IgA antibodies are associated with systemic inflammation and advanced disease in hidradenitis suppurativa. Journal of Allergy and Clinical Immunology. 146(2). 452–455.e5. 31 indexed citations

Goujon, Caroline & H. Bachelez. (2019). Infliximab. Annales de Dermatologie et de Vénéréologie. 146(6-7). 483–486. 3 indexed citations

Puig, L., P.C.M. van de Kerkhof, Kristian Reich, et al.. (2017). A European subset analysis from the population‐based Multinational Assessment of Psoriasis and Psoriatic Arthritis shows country‐specific features: results from psoriasis patients in Spain. Journal of the European Academy of Dermatology and Venereology. 31(7). 1176–1182. 7 indexed citations

Lopez, Anthony, Xavier Mariette, H. Bachelez, et al.. (2017). Vaccination recommendations for the adult immunosuppressed patient: A systematic review and comprehensive field synopsis. Journal of Autoimmunity. 80. 10–27. 94 indexed citations

10.

Gottlieb, J., G. Hickman, Nicolas Guigue, et al.. (2017). 353 Anti–Saccharomyces cerevisiae antibodies (ASCA) are biomarkers of moderate-to-severe hidradenitis suppurativa (HS), but not of severe plaque psoriasis: Results from a prospective, multicenter study. Journal of Investigative Dermatology. 137(10). S253–S253. 1 indexed citations

11.

Tauber, M., Élodie Bal, Xue-Yuan Pei, et al.. (2016). IL36RN Mutations Affect Protein Expression and Function: A Basis for Genotype-Phenotype Correlation in Pustular Diseases. Journal of Investigative Dermatology. 136(9). 1811–1819. 71 indexed citations

12.

Gottlieb, Alice B., Sascha Gerdes, J.‐P. Lacour, et al.. (2016). 052 Efficacy of ixekizumab in moderate-to-severe psoriasis patients who have or have not received prior biologic therapies: An integrated analysis of 3 phase 3 studies. Journal of Investigative Dermatology. 136(9). S169–S169. 5 indexed citations

13.

Viguier, M., H. Bachelez, Béatrice Poirier, et al.. (2014). Peripheral and Local Human Papillomavirus 16–Specific CD8+ T-Cell Expansions Characterize Erosive Oral Lichen Planus. Journal of Investigative Dermatology. 135(2). 418–424. 19 indexed citations

14.

Soltani‐Arabshahi, Razieh, Christophe Lebœuf, Jacqueline Rivet, et al.. (2009). Bcl-xL Gene Expression Correlated with Lower Apoptotic Cell Numbers and Shorter Progression-Free Survival in PCFCL. Journal of Investigative Dermatology. 129(7). 1703–1709. 13 indexed citations

15.

Richette, Pascal, M. Viguier, H. Bachelez, & Thomas Bardin. (2007). Psoriasis induced by anti-tumor necrosis factor therapy: a class effect?. PubMed. 34(2). 438–9. 20 indexed citations

16.

Fazilleau, Nicolas, H. Bachelez, Marie‐Lise Gougeon, & M. Viguier. (2007). Cutting Edge: Size and Diversity of CD4+CD25high Foxp3+ Regulatory T Cell Repertoire in Humans: Evidence for Similarities and Partial Overlapping with CD4+CD25− T Cells. The Journal of Immunology. 179(6). 3412–3416. 49 indexed citations

17.

Poulalhon, Nicolas, É. Bégon, Célèste Lebbé, et al.. (2006). A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunity. British Journal of Dermatology. 156(2). 329–336. 68 indexed citations

18.

Viguier, M., Fabrice Lemaı̂tre, O Vérola, et al.. (2004). Foxp3 Expressing CD4+CD25high Regulatory T Cells Are Overrepresented in Human Metastatic Melanoma Lymph Nodes and Inhibit the Function of Infiltrating T Cells. The Journal of Immunology. 173(2). 1444–1453. 561 indexed citations breakdown →

19.

Bachelez, H., B. Flageul, Louis Dubertret, et al.. (1998). Treatment of Recalcitrant Plaque Psoriasis with a Humanized Non-depleting Antibody to CD4. Journal of Autoimmunity. 11(1). 53–62. 42 indexed citations

20.

Bachelez, H., et al.. (1996). Disseminated varioliform pustular eruption due to Mycobacterium avium intracellulare in an HIV-infected patient.. PubMed. 134(4). 801–3. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact